Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell × pegaspargase × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 37 Leukemia 16 Lymphoma 7 Burkitt Lymphoma 6 Recurrence 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Biphenotypic, Acute 3 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Leukemia, T-Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, B-Cell 1 Immunoproliferative Disorders 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Blast Crisis 1

Interventions

Cyclophosphamide 13 Etoposide 9 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Doxorubicin 7 Brentuximab Vedotin 7 romidepsin 6 fludarabine phosphate 6 Whole-Body Irradiation 6 Vincristine 6 Melphalan 6 fludarabine 5 Rituximab 5 Mycophenolic Acid 5 Granulocyte Colony-Stimulating Factor 4 Gemcitabine 4 Busulfan 4 10-propargyl-10-deazaaminopterin 4 pembrolizumab 3 etoposide phosphate 3 Tacrolimus 3 Lenalidomide 3 Filgrastim 3 Cytarabine 3 Carmustine 3 Antilymphocyte Serum 3 thymoglobulin 2 prednylidene 2 deltacortene 2 carmustine, poliferprosan 20 drug combination 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡